PEN Q4 2025 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$385M+22.1% YoY

Gross Profit

$262M68.0% margin

Operating Income

$59M15.4% margin

Net Income

$47M12.3% margin

EPS (Diluted)

$1.20

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

$86M

Free Cash Flow

$68M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$399M

Stockholders' Equity

$1.4B

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$385M	$316M	+22.1%
Gross Profit	$262M	$211M	+24.4%
Operating Income	$59M	$43M	+38.5%
Net Income	$47M	$34M	+40.6%

Geographic Segments

UNITED STATES

$299M100%